Form Type: 4

SEC EDGAR Link
Accession Number:0001179110-20-007590
Date:2020-06-18
Issuer: CELLDEX THERAPEUTICS, INC. (CLDX)
Original Submission Date:

Reporting Person:

MARUCCI ANTHONY S
C/O CELLDEX THERAPEUTICS, INC.
53 FRONTAGE ROAD HAMPTON, NJ 08827

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
INCENTIVE STOCK OPTION (RIGHT TO BUY) 10.38 2020-06-18 deemed execution date A 245,000 (a) 2021-06-18 2030-06-18 common stock 245,000 $10.38 245,000 direct
Footnotes
IDfootnote
f1 represents option granted by the issuer pursuant to its 2008 stock option and incentive plan.
f2 25% vest on june 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
WhaleWisdom Logo

Elevate your investments